YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Bioavailability of Microspheres Containing Felodipine

필로디핀이 함유된 미립구의 생체이용률

  • 양재헌 (우석대학교 약학대학) ;
  • 나성범 (한화그룹(주)에이치팜 의약연구소) ;
  • 김영일 (우석대학교 약학대학) ;
  • 김남순 (우석대학교 약학대학)
  • Published : 2000.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Microspheres of felodipine, which is one of the calcium channel blocker using a mixture of Eudragi $t^{R}$ RL, L, E, and cellulose on the base of Eudragi $t^{R}$ RS were investigated. Cremopho $r^{R}$ was added to each preparation of polymers in order to increase the release of felodipine from microspheres. Felodipine-loaded microspheres were prepared by a solvent evaporation method, which is based on dispersion of methylene chloride containing felodipine and polymers in 0.5 w/v % polyvinyl alcohol solution. The average diameter based on the size distribution of the felodipine-loaded microspheres was observed to be ca. 40-55 ${\mu}{\textrm}{m}$. A good and smooth surface were showed in all types of the microspheres. The amount of felodipine loaded was over 90 w/w % in all types of microspheres. The dissolution profiles of felodipine from microspheres were similar with each type of polymer, and about a 60 w/w % of the total amount of felodipine loaded to microsphere was released within 7 hours. Dissolution rate of felodipine from the microsphere was increased by addition of Cremophor. After oral administration of the felodipine-loaded microspheres in PVA solution and felodipine alone in PEG solution to rats, respectively, the pharmacokinetic study revealed that the Tmax values of the microspheres were observed in the range of 0.67~l.0 hr while that of the felodipine solution was obtained 0.33 hr. In addition, the AUC of the microspheres at 0 to 7 hr was remarkably increased in comparison to that of felodipine solution. These results revealed that the microspheres based on Eudragit RS could be a good candidate for the controlled release drug delivery system for felodipine.e.e.e.

Keywords

References

  1. J.Kor.Pharm.Sci. v.24 no.41 Controlled drug delivery of ampicillin-ploy(L-lactic acid)films for the treatment of otitis media La S.B.;Jeong S.Y.;Park K.D.;Juhn S.K.;Goo H.C.;Yang S.E.;Jee U.K.
  2. Arch.Pharm.Res. v.19 no.30 Preparation of biodegradable microspheres containing water-soluble drug,β-lactam antibiotic Kim J.H.;Kwon I.C.;Kim Y.H.;La S.B.;Sohn Y.T.;Jeong S.Y.
  3. Arch.Pharm.Res. v.19 no.106 Preparation of sodium alginate microspheres containing hydrophilic β-lactam antibiotics Chun K.H.;Kwon I.C.;Kim Y.H.;La S.B.;Sohn Y.T.;Jeong S.Y.
  4. Eur.J.Pharm.Biopharm. v.39 no.173 Drug-loaded nnoparticles-Preparation methods and drug targeting issues Allemann E.;Gurny R.;Doelker E.
  5. J.Pharm.Pharmacol v.31 no.331 Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: perpatation,morphological and sorptive properties Couvreur P.;Kante B.;Roland M.;Guiot P.;Bauduin P.;Speiser P.
  6. J.Pharm.Sci. v.85 no.85 Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(β-benzy L-aspartate)block cololymer micelles La S.B.;Okano T.;Kataoka K.
  7. Advanced biomaterials in biomedical engineering and drug delivery systems Development of polymeric micelles for drug delivery of indomethacin La S.B.;Kataoka K.;Okano T.;Sakurai Y.;Ogata N.;Kim S.W.;Feijen J.;Okano T.(Eds.)
  8. ACS Symposium Series no.680 Poly(ethylene glycol)-based micelles for drug delivery;Poly(ethylene glycol)Chemistry and Biolobical Applications La S.B.;Nagasaki Y.;Kataoka K.;Harris J.M.;Zalipsky S.(Eds.)
  9. Aqueous polymeric coating for pharmaceuticals dosage forms(2nd ed.) McGinity J.W.
  10. J.Inclusion Phenomena and Molecular Recognition in Chemistry v.30 no.234 Studies on inclusion complex for felodipine with β-cyclodextrin Mielcarek J.
  11. Langmuir v.15 no.3710 Solubilization of sparingly soluble active compounds in lecithin-based microemulsions:Influence on phase behavior and microstructure Corswant C.V.;Thoren P.E.G.
  12. Pharm.Res. v.11 no.1093 Evaluation of solubilizers in the drug release testing of hydrophilic matrix extended-release tablets of felodipine Abrahamsson B.;Johansson D.;Torstensson A.;Wingstrand K.
  13. J.Pharm.Sci. v.83 no.1537 Use of supercritical fluid extraction for sample preparation of sustained-release felodipine tablets Howard A.L.;Shah M.C.;Ip D.P.;Brools M.A.;Strode III J.;T.;Taylor L.T.
  14. Int.J.Pharm. v.131 no.183 Investigation of the effect of different adjuvants on felodipine release kinetics from sustained release monolithic films Acarturk F.;Sencan A.
  15. J.Pharm.Sci. v.75 no.57 Sustained release of nifedipine from granules Kohri N.;Mori K.I.;Miyazaki K.;Arita T.
  16. J.Chromatography A v.707 no.245 Simultaneous determination of enalapril, felodipine and their degradation products in the dosage formulation by reversed-phase higi-perfomance liquid chromatography using a spherisorb C8 column Qin X.-Z;DeMarco J.;Ip D.P.
  17. J.Pharm.Sci. v.83 no.1537 Use of supercritical fluid extraction for sample preparation of sustained-release felodipine tablet Howard A.L.;Shah M.C.;Ip D.P.;Brooks M.A.;Strode III J.T.;Taylor L.T.
  18. J.Antibiot v.37 no.901 Cefodizime,an aminothiazolyl cephalosporin II Comparative studies on the pharmacokinetic behavior in laboratory animals Klessel N.;Limbert M.;Seeger K.;Seibert G.;Winkler I.;Schrinner E.
  19. Antimicrob Agents Chemother v.35 no.14 Antibacterial activities in vitro and in vivo and pharmacokinetics of cefqinome(HR IIIV) a new broad-spectrum cephalosporin Limbert M.;Isert D.;Klessel N.;Markus A.;Seeger K.;Seibert G.;Schrinner E.
  20. J.Kor.Pharm.Sci. v.22 no.267 Preparation and evaluation of sustained-release Eudragit?microcapsules containing β-lactam antibiotics Han K.;Shin D.S.;Jee U.K.;Chung Y.B.
  21. Int.J.Pharm. v.98 no.157 Influence of manufacturing parameters on the size characteristics nd the release profiles of nifedipine from poly(DL-lactide-co-glycolide)microspheres Sansdrap P.;Moes A.J.